The use of NGS sequencing in Illumina technology as a method for examining the genetic variability of the SARS-CoV-2 virus
- 19 December 2024
- journal article
- Published by Index Copernicus in Diagnostyka Laboratoryjna
- Vol. 60 (4) , 296-307
Abstract
Next-Generation Sequencing (NGS) is an advanced technology that enables quick and precise analyzes of DNA and RNA sequences. The use of the Illumina MiniSeq NGS platform (Illumina, USA) for sequencing the SARS-CoV-2 coronavirus genome allows for accurate identification of the virus, analysis of its genetic variants and monitoring of its evolution. It is a valuable tool supporting epidemiological research, developing effective strategies to combat the virus and better understanding the COVID-19 disease it causes.Molecular surveillance of the genetic variability of the SARS-CoV-2 virus using this technology has been carried out at the Interdisciplinary Molecular Research Laboratory at the Provincial Sanitary and Epidemiological Station in Katowice since September 2021. NGS sequencing is used to identify and track new variants and subvariants of the SARS-CoV-2 virus in the Silesian, Lesser Poland and Opole Voivodeships. During research at the WSSE laboratory in Katowice, many SARS-CoV-2 variants with different levels of infectivity and consequences for public health were documented, i.e. Alpha (B.1.1.7), Gamma (P.1), Delta (B.1.617. 2) or Omicron (B.1.1.529).Keywords
This publication has 36 references indexed in Scilit:
- Evaluation of next generation sequencing approaches for SARS-CoV-2Heliyon, 2023
- Evaluation of Illumina® COVIDSeq™ as a tool for Omicron SARS-CoV-2 characterisationJournal of Virological Methods, 2023
- A comparison of five Illumina, Ion Torrent, and nanopore sequencing technology-based approaches for whole genome sequencing of SARS-CoV-2European Journal of Clinical Microbiology & Infectious Diseases, 2023
- Optimization of the Illumina COVIDSeq™ protocol for decentralized, cost-effective genomic surveillancePractical Laboratory Medicine, 2023
- Optimizing the Illumina COVIDSeq laboratorial and bioinformatics pipeline on thousands of samples for SARS-CoV-2 Variants of Concern trackingComputational and Structural Biotechnology Journal, 2022
- Genetic Variants of SARS-CoV-2—What Do They Mean?JAMA, 2021
- Essential interpretations of bioinformatics in COVID-19 pandemicMeta Gene, 2021
- Genomic characterization of a novel SARS-CoV-2Gene Reports, 2020
- Overview of Next‐Generation Sequencing TechnologiesCurrent Protocols in Molecular Biology, 2018
- Next generation sequencing technology: Advances and applicationsBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014